Comparison of therapeutic strategies for aortic stenosis between transcatheter and surgical aortic valve implantation: a retrospective cohort study in Japanese dialysis patients

Table 2 Adverse events

Types of events, n (%)	≤ 30 days			One year
Types of events, n (%)	SAVR	TAVI	p value	SAVR	TAVI	p value
All-cause mortality	0 (0.0%)	0 (0.0%)	–	2 (8.0%)	3 (9.1%)	1.0
Bleeding episodes	1 (4.0%)	1 (3.0%)	1.0	3 (12.0%)	1 (3.0%)	0.305
Stroke	1 (4.0%)	0 (0.0%)	0.431	3 (12.0%)	0 (0.0%)	0.075
De novo permanent pacemaker implantation	1 (4.0%)	0 (0.0%)	0.431	1 (4.0%)	0 (0.0%)	0.431
New onset of vascular complications	0 (0.0%)	1 (3.0%)	1.0	0 (0.0%)	1 (3.0%)	1.0
Device failure	0 (0.0%)	3 (9.1%)	0.251	3 (12.0%)	3 (9.1%)	1.0
Re-admission	1 (4.0%)	3 (9.1%)	0.627	10 (40.0%)	11 (33.3%)	0.520

SAVR surgical aortic valve replacement, TAVI transcatheter aortic valve replacement

ISSN: 2059-1381